Gender-specific care of diabetes (Q43267036)

17 November 2017

Gender-specific care of diabetes (English)

1 reference

17 November 2017

Auryan Szalat

1

1 reference

PubMed ID

19803983

17 November 2017

Itamar Raz

series ordinal

2

1 reference

17 November 2017

1 November 2007

1 reference

17 November 2017

1 reference

17 November 2017

3

1 reference

17 November 2017

6

1 reference

17 November 2017

735-764

1 reference

Report of the expert committee on the diagnosis and classification of diabetes mellitus

17 November 2017

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Mortality trends in men and women with diabetes, 1971 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Gender-specific care of the patient with diabetes: review and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Follow-up report on the diagnosis of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Relationships of fasting and postload glucose levels to sex and alcohol consumption. Are American Diabetes Association criteria biased against detection of diabetes in women?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Adiposity compared with physical inactivity and risk of type 2 diabetes in women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Aromatase-deficient (ArKO) mice accumulate excess adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Oestrogen deficiency in men: where are we today?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Glycaemic control and hormone replacement therapy: implications of the Postmenopausal Estrogen/Progestogen Intervention (PEPI) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Direct effects of sex steroid hormones on adipose tissues and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Intrinsic regional differences in androgen receptors and dihydrotestosterone metabolism in human preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Gender differences in the metabolic syndrome and their role for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

The link between abdominal obesity, metabolic syndrome and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Is visceral obesity the cause of the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Molecular understanding of hyperglycemia's adverse effects for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

The epidemiology of Type 1 diabetes mellitus is not the same in young adults as in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Standards of medical care in diabetes--2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Epidemiology of diabetic retinopathy and macular oedema: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Retinal vascular calibre and the risk of coronary heart disease-related death

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Diabetic nephropathy: diagnosis, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Gender and the progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

The AT2 gene may have a gender-specific effect on kidney function and pulse pressure in type I diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Diabetic neuropathies: a statement by the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

The prevalence of neuropathy and relationship with risk factors in diabetic patients: a single-center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Potential risk factors for diabetic neuropathy: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascul

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Recent development of ischaemic heart disease in sex difference

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Influence of sex on in-hospital outcomes and long-term survival after contemporary percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Sex-specific effects of diabetes on adverse outcomes after percutaneous coronary intervention: trends over time.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Gender difference in the impact of type 2 diabetes on coronary heart disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Does androgen excess contribute to the cardiovascular risk profile in postmenopausal women with type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Sex differences in the effect of diabetes duration on coronary heart disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Diabetes mellitus as a contributor to the risk of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Women and heart disease: the role of diabetes and hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Gender differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Drug treatment of hyperlipidemia in women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Impact of gender on statin efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

C-reactive protein (CRP)-lowering agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Sex-specific determinants of left ventricular mass in pre-diabetic and type 2 diabetic subjects: the Augsburg Diabetes Family Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

C-reactive protein and glycemic control in adults with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Increasing prevalence of the metabolic syndrome among u.s. Adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Components of the "metabolic syndrome" and incidence of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Metabolic syndrome may be a risk factor for early carotid atherosclerosis in women but not in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Metabolic syndrome increases the risk of ischemic stroke in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Sex differences in coagulation and fibrinolysis in white subjects with non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Use of aspirin to reduce risks of cardiovascular disease in patients with diabetes: clinical and research challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Stroke associated with diabetes among Canadians: sex and age differences

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Risk of stroke in people with type 2 diabetes in the UK: a study using the General Practice Research Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Impact of female gender on prognosis in type 2 diabetic patients with ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: evidence from a cohort of a half-million diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Gender influences beliefs about health and illness in diabetic subjects with severe foot lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

The prevalence of comorbid depression in adults with diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Depression in type 1 diabetes in children: natural history and correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Association between symptoms of depression and glycaemic control may be unstable across gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Coronary artery disease in IDDM. Gender differences in risk factors but not risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Skeletal involvement in patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Bone mineral density of both genders in Type 1 diabetes according to bone composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Lower bone mineral content in children with type 1 diabetes mellitus is linked to female sex, low insulin-like growth factor type I levels, and high insulin requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Alterations in bone characteristics associated with glycemic control in adolescents with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Diabetes and bone loss at the hip in older black and white adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Diabetes mellitus and the risk of non-vertebral fractures: the Tromsø study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Thiazolidinedione use and bone loss in older diabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Pubertal growth in IDDM is determined by HbA1c levels, sex, and bone age.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Sexual dimorphism in insulin sensitivity in adolescents with insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Menstrual cycle differences between women with type 1 diabetes and women without diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Screening women with polycystic ovary syndrome for metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Sexual dysfunction in men and women with endocrine disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Sexual dysfunction in women with type 1 diabetes: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Sexual function and endocrine profile in fertile women with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Gestational diabetes: a review of the current literature and guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Management of gestational diabetes: pharmacologic treatment options and glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Type 2 diabetes in pregnancy: a growing concern

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Periconceptional care of women with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Successful pregnancy in women with type 1 diabetes: from preconception through postpartum care

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Criteria for screening tests for gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

A randomized trial evaluating a predominantly fetal growth-based strategy to guide management of gestational diabetes in Caucasian women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Oral anti-hyperglycemic agents for the management of gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Labor and delivery management for women with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Recurrence of gestational diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Gestational diabetes: the consequences of not treating

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Gestational diabetes: does the presence of risk factors influence perinatal outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Glycemic control in the diabetic pregnancy: is tighter always better?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Differing causes of pregnancy loss in type 1 and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Major congenital malformations after first-trimester exposure to ACE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Type 2 diabetes and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Declining insulin requirement in the late first trimester of diabetic pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Insulin analogues in the treatment of diabetes in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Hormonal contraception in women with diabetes mellitus: special considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Contraception in perimenopausal women with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Effects of the menstrual cycle on medical disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Diabetes and the menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Gestational Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Differential roles of the insulin and insulin-like growth factor-I (IGF-I) receptors in response to insulin and IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Structural biology of insulin and IGF1 receptors: implications for drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

A comparison of glyburide and insulin in women with gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Glyburide for the treatment of gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Pregnancy in women with Type 2 diabetes: who takes metformin and what is the outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughou

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Metformin before and during pregnancy and lactation in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.3.6.735

21 January 2018

Identifiers

DOI

10.2217/17455057.3.6.735

1 reference

17 November 2017

1 reference

PubMed ID

19803983